Table 2.
Autoantibodies | Clinical significance | Refs |
---|---|---|
ANA | Poor prognosis and a significant higher respiratory rate. | [14] |
APL | Poor prognosis and a significant higher respiratory rate. Possible association with a hyperinflammatory state and thrombosis and thromboembolism. |
[14,51] |
Lupus anticoagulant | A higher rate of thrombosis | [50] |
Cold agglutinins | Hemolytic anemia. Complicating laboratory assessment and renal replacement therapy. |
[54,57] |
Anti-Ro/SSA antibodies | Possible association with severe pneumonia. | [55] |
anti-Caspr2 antibody | Unclear. | [53] |
anti- GD1b antibody | Unclear. | [53] |
Anti-MOG antibody | Unclear. | [52] |
Red cell –bound antibodies | Associated with the severity of anemia. | [56] |